论文部分内容阅读
目的观察低分子肝素治疗不稳定型心绞痛的疗效及价值。方法64例不稳定型心绞痛(UA)患者随机分为低分子肝素组和对照组,对照组给予常规治疗,肝素组同时给予低分子肝素。观察心绞痛缓解率及血液黏稠度指标和血小板计数,治疗前后心电图改变。结果低分子肝素治疗组:总有效率88·9%,与对照组比较差异有极显著性意义(P<0·01)。结论早期使用低分子量肝素治疗不稳定型心绞痛疗效确切,并可使患者心电图、血液流变学有明显改善。
Objective To observe the efficacy and value of low molecular weight heparin in the treatment of unstable angina pectoris. Methods Sixty-four patients with unstable angina pectoris (UA) were randomly divided into low molecular weight heparin group and control group, while those in control group were given routine treatment. Low molecular weight heparin was given concurrently in heparin group. Angina pectoris rate and blood viscosity index and platelet count were observed before and after treatment, ECG changes. Results Low molecular weight heparin treatment group: the total effective rate of 88.9%, compared with the control group was significantly different (P <0.01). Conclusion The early use of low molecular weight heparin in the treatment of unstable angina pectoris has an exact effect and can significantly improve the electrocardiogram and hemorheology in patients.